Black Diamond Therapeutics
BDTX
BDTX
76 hedge funds and large institutions have $107M invested in Black Diamond Therapeutics in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.73% more ownership
Funds ownership: 72.11% → 73.84% (+1.7%)
0% more capital invested
Capital invested by funds: $107M → $107M (+$365K)
Holders
76
Holding in Top 10
–
Calls
$186K
Puts
$29K
Top Buyers
| 1 | +$4.99M | |
| 2 | +$3.94M | |
| 3 | +$1.95M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.12M |
| 5 |
Two Sigma Investments
New York
|
+$807K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$2.67M | |
| 3 | -$1.82M | |
| 4 |
EP
Eversept Partners
New York
|
-$968K |
| 5 |
JPMorgan Chase & Co
New York
|
-$804K |